Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vedanta Biosciences Inc.

www.vedantabio.com

Latest From Vedanta Biosciences Inc.

Finance Watch: Deerfield Invests $635m In New York Start-Ups, Pledges $2bn Globally By 2030

Private Company Edition: Deerfield is funding a new life science campus. Also, BioFractura gets up to $67.4m in BARDA contract in recent grant and government deal surge, Mission Bay raises a $60m fund and Amphivena closes a $62m VC round.

StartUps and SMEs Financing

Could The Gut Cure Brain Disease?

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity. 

Innovation Research and Development Strategies

Ferring Favorite To Get First Approval For Microbiota-Based Therapy

If all goes well, 2020 could see the Swiss firm's Rebiotix subsidiary get a green light from the FDA for its recurrent Clostridioides difficile fecal product.

Infectious Diseases Clinical Trials

Gelesis's Obesity Product FDA Acceptance Gives Boost To PureTech's Portfolio


PureTech's affiliate Gelesis has received FDA clearance for its Plenity capsule to treat overweight-obese adults, and plans to launch it commercially in the second half. 
Approvals Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Immune Disorders
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Vedanta Biosciences
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Vedanta Biosciences Inc.
  • Senior Management
  • Bernat Olle, PhD, CEO
    Bruce L Roberts, PhD, CSO
    Dan Couto , CTO
    Denise Tilton, VP, Clinical Operations
    Dmitri Bobilev, VP, Clinical Dev.
    Justin Chakma, VP, Bus. Dev. & Strategy
    Kevin Coveney, SVP, Fin.
  • Contact Info
  • Vedanta Biosciences Inc.
    Phone: (857) 706-1427
    19 Blackstone St.
    3rd Fl.
    Cambridge, MA 02116
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register